Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Galectin Therapeutics Inc.

Clinical trials sponsored by Galectin Therapeutics Inc., explained in plain language.

Completed 1 Terminated 1

Experimental drug aims to prevent bleeding veins in fatty liver disease

Prevention Terminated

This study tested a drug called belapectin to see if it could prevent the formation of esophageal varices (enlarged veins in the esophagus) in people with NASH cirrhosis and signs of high blood pressure in the liver. The trial enrolled 357 adults and compared belapectin to a plac…

Phase: PHASE2, PHASE3 • Sponsor: Galectin Therapeutics Inc. • Aim: Prevention

Last updated Jul 02, 2026 00:00 UTC